Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.

Adv Prostaglandin Thromboxane Leukot Res

Wyeth Laboratories, Inc., Philadelphia, Pennsylvania 19101.

Published: November 1987

Download full-text PDF

Source

Publication Analysis

Top Keywords

wy-45911 novel
4
novel leukotriene
4
leukotriene antagonist
4
antagonist lipoxygenase
4
lipoxygenase inhibitory
4
inhibitory activity
4
wy-45911
1
leukotriene
1
antagonist
1
lipoxygenase
1

Similar Publications

Wy-45,911 (4-[hydroxy-[3-(2-quinolinylmethoxy)phenyl] amino]-4-oxabutanoic acid, methyl ester) was found to inhibit competitively leukotriene D4 (LTD4)-induced contractions of the isolated guinea pig trachea but not those of leukotriene C4 (LTC4), even in the presence of a gamma-glutamyltranspeptidase inhibitor, reduced glutathione (GSH). Tracheal contractions induced by histamine or pilocarpine were also not significantly altered by Wy-45,911. The drug inhibited the tracheal contractions induced by antigen, even in the presence of GSH.

View Article and Find Full Text PDF

Wy-45,911: a novel leukotriene antagonist with lipoxygenase inhibitory activity.

Adv Prostaglandin Thromboxane Leukot Res

November 1987

Wyeth Laboratories, Inc., Philadelphia, Pennsylvania 19101.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!